Main Article Content
Abstract
Keywords
Article Details
Copyright (c) 2019 Folia Medica Indonesiana
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
-
Folia Medica Indonesiana is a scientific peer-reviewed article which freely available to be accessed, downloaded, and used for research purposes. Folia Medica Indonesiana (p-ISSN: 2541-1012; e-ISSN: 2528-2018) is licensed under a Creative Commons Attribution 4.0 International License. Manuscripts submitted to Folia Medica Indonesiana are published under the terms of the Creative Commons License. The terms of the license are:
Attribution ” You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial ” You may not use the material for commercial purposes.
ShareAlike ” If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions ” You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
You are free to :
Share ” copy and redistribute the material in any medium or format.
Adapt ” remix, transform, and build upon the material.
References
- Ahlqvist E, Ahluwalia TS, Groop L (2011). Genetics of type 2 diabetes. Clinical Chemistry 57, 241-254
- American Diabetes Association (2012). Diagnosis and classification of diabetes mellitus. Diabetes Care 35, 64-71
- American Diabetes Association (2013). Standards of medical care in diabetes 2013. Diabetes Care 36, 11-66
- Baekkeskov S, Aanstoot H-J, Christgau S, Reetz A, Solimena M, Cascalhom, Folli F, Ritcher Olesen H, De Camilli P (1990). Identification of the 64K autoantigen in insulin-diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature (Lond) 347, =151-56
- Banatvala JE, Bryant J, Schernthaner G, Borkenstein M, Schober E, Brown D, De Silva LM, Menser MA, Silink M (1985). Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenileonset insulin-dependent diabetes mellitus in Britain, Austria, and Australia. Lancet 1, 1409-1412
- Clements GB, Galbraith DN, Taylor KW (1995). Coxsackie B virus infection and onset of childhood diabetes. Lancet 346, 221-223
- Coppieters KT, Wiberg A, von Herrath MG (2012). Viral infections and molecular mimicry in type 1 diabetes. APMIS 120, 941-949
- Coppieters KT, Dotta F, Amirian N, Campbell PD, Kay TW, Atkinson MA, ,Roep BO, Von Herrath MG (2012). Demonstration of islet- autoreactive CD8 T cells ininsulitic lesions from recent onset and long-term type 1 diabetes patients. The Journal of Experimental Medicine 209, 51-60
- Erlander MGNJK. Tillakaratne S. Feldblum N, et al (1991). Two genes encode distinct glutamate decarboxylases with different responses to pyridoxal phosphate. Neuron 7, 91-100
- Fujinamia RS, Von Herrath MG, Christen URS, Whitton JL (2006). Molecular mimicry, bystander activation, or viral persistence infections and autoimmune disease. Clinical Microbiology Review, 80-94
- Hamalainen AM, Ronkainen MS, Akerblom HK, Knip M (2000). Postnatal elimination of transplacentally acquired disease-associated antibodies in infants born to families with type 1 diabetes: the Finnish TRIGR Study Group: Trial to Reduce IDDM in the Genetically at Risk. J Clin Endocrinol Metab 85, 4249-4253
- Juneja R, Hirsch IB, Naik RG, et al (2001). Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1(1/2) diabetes in patients presenting with type 2 diabetes. Metabolism 50, 1008-1013
- Koczwara KE, Bonifacio, Ziegler AG (2004). Transmission of maternal islet antibodies and risk of autoimmune diabetes in offspring of mothers with type 1 diabetes. Diabetes 53, 1-4
- Leiser R, Kaufmann P (1994). Placental structure: In a comparative aspect. experimental and clinical endo-crinology, 102, 122-134. http://dx.doi.org/10.1055/s-0029-1211275
- Newsholme P, Keane K, et al (2013). The impact of inflammation on pancreatic íŸ-cell metabolism, function and failure in T1DM and T2DM: Commonalities and differences. Intech
- Ozougwu KC, Obimba CD, Belonwu CB, Unakalamba (2013). The pathogenesis and pathophysiology of type 1 and type 2 diabetes melitus J. Physiol. Pathophysiol 4, 46-57
- Pociot F, McDermott MF (2002). Genetics of type 1 diabetes mellitus (Review). Genes Immun 3, 235-249
- Pranoto A, Sutjahjo A, Tjokroprawiro A, Murtiwi S, Wibisono S (2011). Konsensus pengelolaan dan pencegahan diabetes melitus tipe 2 di Indonesia 2011. LPPM , Universitas Airlangga, Surabaya
- Serreze DV, Ottendorfer EW, Ellis TM, Gauntt CJ, Atkinson MA (2000). Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes 49, 708-711
- Shulman LM, Hampe CS, Ben- Haroush A, et al (2014). Antibodies to islet cell autoantigens, rota-viruses and/or enteroviruses in cord blood and healthy mothers in relation to the 2010-2011 winter viral seasons in Israel: a pilot study Diabet Med 31, 681-685
- Tedjapranata M (2009). Diabetes di usia lanjut memang berbahaya, namun dapat dijinakkan. Available at: http://www.gbimawarsaron.com/kesehatan/27-diabe-tes- mellitus. Accesed March 12, 2016
- Tuomi T, Carlsson í…, Li H, Isomaa A, Miettinen A, Nissén M, Ehrnström B-J, Forsén B, Snickars B, Lahti K, Forsblom C, Saloranta C, Taskinen M-R, Groop LC (1999). Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48, 150-157
- Uibo R, Lernmark A (2008). GAD65 autoimmunity-clinical studies. Adv Immunol 100, 39-78
- WHO (1999). Definition, diagnosis and classification of diabetes mellitus and its complications, report of a WHO Consultation World Health Organization, De-partment of Non communicable Disease Surveillance, Geneva
References
Ahlqvist E, Ahluwalia TS, Groop L (2011). Genetics of type 2 diabetes. Clinical Chemistry 57, 241-254
American Diabetes Association (2012). Diagnosis and classification of diabetes mellitus. Diabetes Care 35, 64-71
American Diabetes Association (2013). Standards of medical care in diabetes 2013. Diabetes Care 36, 11-66
Baekkeskov S, Aanstoot H-J, Christgau S, Reetz A, Solimena M, Cascalhom, Folli F, Ritcher Olesen H, De Camilli P (1990). Identification of the 64K autoantigen in insulin-diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature (Lond) 347, =151-56
Banatvala JE, Bryant J, Schernthaner G, Borkenstein M, Schober E, Brown D, De Silva LM, Menser MA, Silink M (1985). Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenileonset insulin-dependent diabetes mellitus in Britain, Austria, and Australia. Lancet 1, 1409-1412
Clements GB, Galbraith DN, Taylor KW (1995). Coxsackie B virus infection and onset of childhood diabetes. Lancet 346, 221-223
Coppieters KT, Wiberg A, von Herrath MG (2012). Viral infections and molecular mimicry in type 1 diabetes. APMIS 120, 941-949
Coppieters KT, Dotta F, Amirian N, Campbell PD, Kay TW, Atkinson MA, ,Roep BO, Von Herrath MG (2012). Demonstration of islet- autoreactive CD8 T cells ininsulitic lesions from recent onset and long-term type 1 diabetes patients. The Journal of Experimental Medicine 209, 51-60
Erlander MGNJK. Tillakaratne S. Feldblum N, et al (1991). Two genes encode distinct glutamate decarboxylases with different responses to pyridoxal phosphate. Neuron 7, 91-100
Fujinamia RS, Von Herrath MG, Christen URS, Whitton JL (2006). Molecular mimicry, bystander activation, or viral persistence infections and autoimmune disease. Clinical Microbiology Review, 80-94
Hamalainen AM, Ronkainen MS, Akerblom HK, Knip M (2000). Postnatal elimination of transplacentally acquired disease-associated antibodies in infants born to families with type 1 diabetes: the Finnish TRIGR Study Group: Trial to Reduce IDDM in the Genetically at Risk. J Clin Endocrinol Metab 85, 4249-4253
Juneja R, Hirsch IB, Naik RG, et al (2001). Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1(1/2) diabetes in patients presenting with type 2 diabetes. Metabolism 50, 1008-1013
Koczwara KE, Bonifacio, Ziegler AG (2004). Transmission of maternal islet antibodies and risk of autoimmune diabetes in offspring of mothers with type 1 diabetes. Diabetes 53, 1-4
Leiser R, Kaufmann P (1994). Placental structure: In a comparative aspect. experimental and clinical endo-crinology, 102, 122-134. http://dx.doi.org/10.1055/s-0029-1211275
Newsholme P, Keane K, et al (2013). The impact of inflammation on pancreatic íŸ-cell metabolism, function and failure in T1DM and T2DM: Commonalities and differences. Intech
Ozougwu KC, Obimba CD, Belonwu CB, Unakalamba (2013). The pathogenesis and pathophysiology of type 1 and type 2 diabetes melitus J. Physiol. Pathophysiol 4, 46-57
Pociot F, McDermott MF (2002). Genetics of type 1 diabetes mellitus (Review). Genes Immun 3, 235-249
Pranoto A, Sutjahjo A, Tjokroprawiro A, Murtiwi S, Wibisono S (2011). Konsensus pengelolaan dan pencegahan diabetes melitus tipe 2 di Indonesia 2011. LPPM , Universitas Airlangga, Surabaya
Serreze DV, Ottendorfer EW, Ellis TM, Gauntt CJ, Atkinson MA (2000). Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes 49, 708-711
Shulman LM, Hampe CS, Ben- Haroush A, et al (2014). Antibodies to islet cell autoantigens, rota-viruses and/or enteroviruses in cord blood and healthy mothers in relation to the 2010-2011 winter viral seasons in Israel: a pilot study Diabet Med 31, 681-685
Tedjapranata M (2009). Diabetes di usia lanjut memang berbahaya, namun dapat dijinakkan. Available at: http://www.gbimawarsaron.com/kesehatan/27-diabe-tes- mellitus. Accesed March 12, 2016
Tuomi T, Carlsson í…, Li H, Isomaa A, Miettinen A, Nissén M, Ehrnström B-J, Forsén B, Snickars B, Lahti K, Forsblom C, Saloranta C, Taskinen M-R, Groop LC (1999). Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48, 150-157
Uibo R, Lernmark A (2008). GAD65 autoimmunity-clinical studies. Adv Immunol 100, 39-78
WHO (1999). Definition, diagnosis and classification of diabetes mellitus and its complications, report of a WHO Consultation World Health Organization, De-partment of Non communicable Disease Surveillance, Geneva